☰

Negin Hatami - Publications

Affiliations: 
2015-2016 Radiology Stanford University, Palo Alto, CA 
Tree Info Similar researchers PubMed Report error

21 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2022 Wardak M, Sonni I, Fan AP, Minamimoto R, Jamali M, Hatami N, Zaharchuk G, Fischbein N, Nagpal S, Li G, Koglin N, Berndt M, Bullich S, Stephens AW, Dinkelborg LM, et al. F-FSPG PET/CT Imaging of System x Transporter Activity in Patients with Primary and Metastatic Brain Tumors. Radiology. 203296. PMID 35191738 DOI: 10.1148/radiol.203296  0.395
2021 Duan H, Baratto L, Hatami N, Liang T, Mari Aparici C, Davidzon GA, Iagaru A. Ga-PSMA11 PET/CT for biochemically recurrent prostate cancer: Influence of dual-time and PMT- vs SiPM-based detectors. Translational Oncology. 15: 101293. PMID 34823095 DOI: 10.1016/j.tranon.2021.101293  0.461
2021 Nakamoto R, Ferri V, Duan H, Hatami N, Goel M, Rosenberg J, Kimura R, Wardak M, Haywood T, Kellow R, Shen B, Park W, Iagaru A, Gambhir SS. Pilot-phase PET/CT study targeting integrin αβ in pancreatic cancer patients using the cystine-knot peptide-based F-FP-R1-MG-F2. European Journal of Nuclear Medicine and Molecular Imaging. PMID 34729628 DOI: 10.1007/s00259-021-05595-7  0.309
2021 Baratto L, Toriihara A, Hatami N, Aparici CM, Davidzon G, Levin CS, Iagaru A. Results of a Prospective Trial to Compare Ga-DOTA-TATE with SiPM-Based PET/CT vs. Conventional PET/CT in Patients with Neuroendocrine Tumors. Diagnostics (Basel, Switzerland). 11. PMID 34070751 DOI: 10.3390/diagnostics11060992  0.431
2021 Baratto L, Song H, Duan H, Hatami N, Bagshaw H, Buyyounouski M, Hancock S, Shah SA, Srinivas S, Swift P, Moradi F, Davidzon GA, Iagaru A. PSMA- and GRPR-targeted PET: Results from 50 Patients with Biochemically Recurrent Prostate Cancer. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. PMID 33674398 DOI: 10.2967/jnumed.120.259630  0.444
2021 Nakamoto R, Harrison C, Song H, Guja KE, Hatami N, Nguyen J, Moradi F, Franc BL, Aparici CM, Davidzon G, Iagaru A. The Clinical Utility of F-Fluciclovine PET/CT in Biochemically Recurrent Prostate Cancer: an Academic Center Experience Post FDA Approval. Molecular Imaging and Biology. PMID 33469884 DOI: 10.1007/s11307-021-01583-3  0.442
2020 Song H, Duan H, Harrison C, Guja K, Hatami N, Franc BL, Moradi F, Aparici CM, Davidzon G, Srinivas S, Iagaru A. Prospective evaluation of 18F-DCFPyL PET/CT in biochemically recurrent prostate cancer: Analysis of lesion localization and distribution. Journal of Clinical Oncology. 38: 5556-5556. DOI: 10.1200/Jco.2020.38.15_Suppl.5556  0.448
2020 Baratto L, Song H, Duan H, Aparici CM, Hatami N, Davidzon G, Moradi F, Iagaru A. Lba02-09 Interim Analysis Results Of A Prospective Study Of 68Ga-Rm2 Pet/Mri In Patients With Biochemically Recurrent Prostate Cancer And Negative Conventional Imaging The Journal of Urology. 203. DOI: 10.1097/Ju.0000000000000958.09  0.443
2019 Song H, Harrison C, Duan H, Guja K, Hatami N, Franc B, Moradi F, Mari Aparici C, Davidzon G, Iagaru A. Prospective Evaluation in an Academic Center of F-DCFPyL PET/CT in Biochemically Recurrent Prostate Cancer: A Focus on Localizing Disease and Changes in Management. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. PMID 31628216 DOI: 10.2967/Jnumed.119.231654  0.49
2019 Kimura RH, Wang L, Shen B, Huo L, Tummers W, Filipp FV, Guo HH, Haywood T, Abou-Elkacem L, Baratto L, Habte F, Devulapally R, Witney TH, Cheng Y, Tikole S, ... ... Hatami N, et al. Evaluation of integrin αvβ cystine knot PET tracers to detect cancer and idiopathic pulmonary fibrosis. Nature Communications. 10: 4673. PMID 31611594 DOI: 10.1038/S41467-019-11863-W  0.372
2019 Park SY, Barrato L, Hatami N, Davidzon G, Gambhir SS, Iagaru A. Initial experience with a PET/computed tomography system using silicon photomultiplier detectors. Nuclear Medicine Communications. PMID 31568189 DOI: 10.1097/Mnm.0000000000001088  0.453
2019 Toriihara A, Nobashi T, Baratto L, Duan H, Moradi F, Park S, Hatami N, Aparici C, Davidzon G, Iagaru A. Comparison of three interpretation criteria of Ga-PSMA11 PET based on inter- and intra-reader agreement. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. PMID 31562226 DOI: 10.2967/Jnumed.119.232504  0.503
2019 Baratto L, Duan H, Laudicella R, Toriihara A, Hatami N, Ferri V, Iagaru A. Physiological Ga-RM2 uptake in patients with biochemically recurrent prostate cancer: an atlas of semi-quantitative measurements. European Journal of Nuclear Medicine and Molecular Imaging. PMID 31478089 DOI: 10.1007/S00259-019-04503-4  0.327
2019 Toriihara A, Baratto L, Nobashi T, Park S, Hatami N, Davidzon G, Kunz PL, Iagaru A. Prognostic value of somatostatin receptor expressing tumor volume calculated from Ga-DOTATATE PET/CT in patients with well-differentiated neuroendocrine tumors. European Journal of Nuclear Medicine and Molecular Imaging. PMID 31350603 DOI: 10.1007/S00259-019-04455-9  0.447
2019 Toriihara A, Duan H, Thompson HM, Park S, Hatami N, Baratto L, Fan AC, Iagaru A. F-FPPRGD PET/CT in patients with metastatic renal cell cancer. European Journal of Nuclear Medicine and Molecular Imaging. PMID 30850872 DOI: 10.1007/S00259-019-04295-7  0.469
2019 Nobashi T, Baratto L, Reddy SA, Srinivas S, Toriihara A, Hatami N, Yohannan TK, Mittra E. Predicting Response to Immunotherapy by Evaluating Tumors, Lymphoid Cell-Rich Organs, and Immune-Related Adverse Events Using FDG-PET/CT. Clinical Nuclear Medicine. PMID 30688730 DOI: 10.1097/Rlu.0000000000002453  0.433
2018 Baratto L, Park SY, Hatami N, Gulaka P, Vasanawala S, Yohannan TK, Herfkens R, Witteles R, Iagaru A. F-florbetaben whole-body PET/MRI for evaluation of systemic amyloid deposition. Ejnmmi Research. 8: 66. PMID 30043115 DOI: 10.1186/S13550-018-0425-1  0.344
2018 Park SY, Zacharias C, Harrison C, Fan RE, Kunder C, Hatami N, Giesel F, Ghanouni P, Daniel B, Loening AM, Sonn GA, Iagaru A. Gallium 68 PSMA-11 PET/MR Imaging in Patients with Intermediate- or High-Risk Prostate Cancer. Radiology. 172232. PMID 29786490 DOI: 10.1148/Radiol.2018172232  0.436
2018 Sonni I, Baratto L, Park S, Hatami N, Srinivas S, Davidzon G, Gambhir SS, Iagaru A. Initial experience with a SiPM-based PET/CT scanner: influence of acquisition time on image quality. Ejnmmi Physics. 5: 9. PMID 29666972 DOI: 10.1186/S40658-018-0207-X  0.46
2017 Baratto L, Davidzon GA, Moghbel M, Hatami N, Iagaru A, Mittra ES. Comparison Between Different PET and CT-Based Imaging Interpretation Criteria at Interim Imaging in Patients With Diffuse Large B-Cell Lymphoma. Clinical Nuclear Medicine. PMID 29076913 DOI: 10.1097/Rlu.0000000000001880  0.423
2017 Baratto L, Park SY, Hatami N, Davidzon G, Srinivas S, Gambhir SS, Iagaru A. 18F-FDG silicon photomultiplier PET/CT: A pilot study comparing semi-quantitative measurements with standard PET/CT. Plos One. 12: e0178936. PMID 28582472 DOI: 10.1371/Journal.Pone.0178936  0.474
Show low-probability matches.